News

The Ehlers-Danlos Society is accepting applications for its spring 2020 research grant program. Grants will support research in Ehlers-Danlos syndrome (EDS) and hypermobility spectrum disorders (HSD). Through its Spring 2020 Microgrants program, the society will award about nine grants of up to $5,000 each. These grants are generally…

The gleaming new Dutch headquarters of the European Medicines Agency (EMA), fronting Domenico Scarlattilaan in Amsterdam’s suburban Zuidas business district, finally opened for business last month — just over two years after the European Union decided to relocate the EMA to the Netherlands in the wake of Brexit.

To discuss the latest information about Ehlers-Danlos syndrome (EDS) and related disorders, patients and their families, scientists, and clinicians will convene in Paris from March 21-22 for the first European Learning Conference. Presented by the Ehlers-Danlos Society, and held at the Hotel Mercure Paris Orly Rungis,…

With so much recent publicity surrounding gene therapy, it’s no surprise that the topic was a major focus of the recent 2019 NORD Rare Diseases & Orphan Products Breakthrough Summit. From diagnosis and clinical trial design to manufacturing, pricing strategies, and ethical concerns, gene therapy — both its high…